14:00 CET

Oncopeptides virtuella kapitalmarknadsdag

Programmet

 

14.00 – 16.00 CET (8:00am-10am EST) 30 november 2020

 

“Building a Fully Integrated Biotechnology Company”

  • Introduction and Strategy for Value Growth – Marty J Duvall, CEO Oncopeptides
  • Multiple Myeloma
    “Myeloma remains one of the largest unmet medical needs within hematology”
    o Assistant Professor Joshua Richter, MD. Icahn School of Medicine at Mount Sinai Hospital, New York
  • Relapsed refractory multiple myeloma and melflufen – clinical experience with melflufen – Panel discussion
    o Professor Paul Richardson, MD, Dana-Farber Cancer Institute, Boston
    o Associate Professor Maria-Victoria Mateos, MD, PhD, University Hospital, Salamanca
    Moderated by Klaas Bakker, MD, PhD, CMO Oncopeptides
  • The clinical development program for melflufen
    “Understanding how melflufen can help patients the most” – Jakob Lindberg, CSO Oncopeptides
  • Successfully making the drug available for patients in the US
    Overview of US launch of melflufen – Marty J Duvall, CEO Oncopeptides
  • Questions and Answers

 

Kapitalmarknadsdagen kommer att webbsändas via denna länkhttps://tv.streamfabriken.com/oncopeptides-cmd-2020

Kommande evenemang

Temadag Kommersialisering av läkemedel - Erik Penser Bank

09:00 CET - 17:00 CET

Oncopeptides CFO Anders Martin-Löf presenterar vid Erik Penser Banks temadag Kommersialisering av läkenedel den 6 maj kl 16:15 CET. Temadagen livesänds 09:00-17:00 CET. Välkommen att lyssna på presentationen via länken nedan.

COMy 2021

-

World Congress on Controversies in Multiple Myeloma 2021.

Delårsrapport Q1 2021

08:00 CET

Årsstämma 2021

ASCO 2021 Annual Meeting

-

American Society of Clinical Oncology (ASCO) 2021.

EHA 2021 Virtual Congress

-

European Hematology Association Annual meeting 2021.

Tyst Period

-

Delårsrapport Q2 2021

08:00 CET

Tyst Period

-

Delårsrapport Q3 2021

08:00 CET